Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Addition of stereotactic body radiotherapy to systemic chemotherapy in locally advanced biliary tract cancers
2014-003656-31Phase 2Unknown
- Sponsor
- University College London
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin and gemcitabine in biliary cancer and Bile duct adenocarcinoma (CCA), sponsored by University College London. Primary endpoint: Feasibility. Status: unknown.
02
Drugs
cisplatingemcitabine
03
Conditions
biliary cancerBile duct adenocarcinoma (CCA)
Beyond the preview
Go deeper on 2014-003656-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003656-31.